Navigation Links
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Date:8/19/2007

commercial success, the risk that our other product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later stage clinical trials, the risk that EpiCept will not obtain approval to market any of its product candidates, the risks associated with reliance on additional outside financing to meet its capital requirements, the risks associated with dependence upon key personnel, the risks associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of our product candidates; the cost, delays and uncertainties associated with our scientific research, product development, clinical trials and regulatory approval process; our history of operating losses since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including its reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in EpiCept's filings which are available at http://www.sec.gov or at http://www.epicept.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due to inaccurate assumptions, unknown risks or uncertainties or other risk factors.

EPCT-GEN

*Azixa is a registered trademark of Myriad Genetics, Inc.


'/>"/>
SOURCE EpiCept Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal Therapeutics ... company with a focus on Omega-3 therapies for ... operational highlights and financial results for the fiscal ... referenced herein are in Canadian dollars unless otherwise ... been significant, with the right strategic partners and ...
(Date:4/30/2015)... April 30, 2015  Tandem Diabetes Care ® , Inc. ... of the t:slim ® and t:flex™ Insulin Pumps, today ... 2015. In comparing the first quarter of ... grew 53 percent to $12.3 million from $8.1 million ... from 1,723 pumps "Our investment in resources to ...
(Date:4/30/2015)... 30, 2015  Nektar Therapeutics (Nasdaq: NKTR ) ... ended March 31, 2015. Cash and ... $325.8 million as compared to $262.8 million at December ... at March 31, 2015 includes a $100.0 million milestone ... first commercial sale of Movantik™(naloxegol) in the U.S. ...
Breaking Medicine Technology:Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
(Date:5/2/2015)... 02, 2015 ZoomCare, the Portland-based innovator ... plans to offer its new healthcare insurance to individuals ... Personal Health Insurance System is the nation’s first health ... human performance. ZOOM+ Personal Health Insurance was ZoomCare’s first ... that are subject to review and regulation by the ...
(Date:5/1/2015)... IDLife LLC, a health and wellness ... the addition of its newest partner and fitness celebrity, ... athlete, growing up in gymnastics and competitive diving, but ... a personal trainer and helping others achieve their fitness ... TV shows highlighting her stunning physique and unique training ...
(Date:5/1/2015)... 01, 2015 Pioneer Millworks, the largest ... latest in their reclaimed wood products at the 27th ... Javits Center in NYC this May. Their newest offerings, ... much anticipated texture and color to North America's platform ... of texture and color in the design world and ...
(Date:5/1/2015)... ME (PRWEB) May 01, 2015 Royal ... in Freeport, Maine, reports on a new study that ... stiffness, joint swelling and improved physical function as well ... with severe osteoarthritis of the knee. , The report ... Natural Insights for Well Being® ,” which Royal River ...
(Date:5/1/2015)... 01, 2015 TROY Healthcare Solutions is ... Regional User Group (RUG) Conference in Atlanta, GA from ... User Group Conference provides a forum for client-to-client presentations, ... all aspects of electronic medical record operations, as well ... applications. , In addition to sponsoring the event, TROY ...
Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... stress may take a toll on your heart, researchers say, ... in long hours at work increase their risk of dying ... In fact, people who work three or more hours of ... heart-related problems such as dying from heart disease, having a ...
... ... manager spends up to 40% of the workweek addressing employee conflict? Conflict ... a new chord by providing a resource for managers to outsource their ... the equivalent of up to two (2) business days a week worth ...
... ... Interpretive Dance Video. , ... Seattle, WA (PRWEB) May 11, 2010 -- Onlineshoes.com is proud to announce the ... featuring an interpretive dance video. , , ,Pronounced “cushy”, Cushe is a new ...
... Melanoma and other ... linked to cancer risk. Practical and clinical information about skin health, melanoma and skin cancer ... , ... With skin cancer on the rise for Americans under 30 and indoor tanning contributing to ...
... ... ... the MTA is keeping some residents in Brooklyn up at night. Meg Richichi has been calling ... attorneys in New York are familiar with the compromise between construction safety and convenience., , ...
... ... Coral Gables (Miami) Florida, Medical Equipment Solutions has been providing services ... Their experts have a passion for helping customers improve their quality ... and oxygen concentrators, the specialists at MES have the experience to ...
Cached Medicine News:Health News:Overtime Boosts Heart Attack Risk 2Health News:Overtime Boosts Heart Attack Risk 3Health News:Conflict Boss Brings Sanity Back to the Workplace and Lets Managers Get Back to Managing 2Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 2Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 3Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 2Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 3Health News:New York Construction Accident Attorney, David Perecman, Supports MTA Night Work 2Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 2Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 3Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 4Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 5
Make better prescribing decisions with this drug interaction analyzer containing over 3,000 brand names with generic equivalents....
... Guide for Physicians - ... Integrated Calculators - combines ... and practical drug resource ... dosing calculation tools for ...
AnesthesiaDrugs™ is the handheld version of Sota Omoigui's Anesthesia Drugs Handbook, the best selling clinical guide to essential anesthesia and critical care drug information....
... drug information reference that integrates ... patient care guidelines., The sixth ... 4,700 drugs, including the latest ... indications, dosages, side effects and ...
Medicine Products: